Tender detail

Non-exclusive rebate agreement for medicines containing apixaban

Summary

DAK-Gesundheit intends to conclude rebate agreements for medicines containing apixaban (ATC B01AF02) with as many interested pharmaceutical companies as possible. The agreements will run from 1 December 2026 to 30 November 2028, with an option to extend for one 12-month period, and will end when a new exclusive agreement takes effect.

Reference number
a88bce76-6030-469f-800d-e7a33f687da7
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2029-10-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.